The Computational Bioscience Research Center (CBRC) at King
Abdullah University of Science and Technology (KAUST) and GI Oncology Unit
(GIOU) of King Abdulaziz University Hospital at King Abdulaziz University, have
signed a research agreement on “The Role of Gut Microbes in Development of
Malignant Pancreatic Cysts in Saudi Patients.”
research is funded through KAUST Center Partnership Funds. To the best of our
knowledge, the research is the first one in the Kingdom to use Medical Metagenomics
in clinical pancreatic cancer research.
The study aims to investigate if
microbial communities in pancreatic cysts can differentiate cysts that turn
into a malignant form from those that remain benign. The successful outcomes
could open the way to novel diagnostic methods of pancreatic malignancies and
more closer precision medicine. PI at GIOU is Assistant Professor Emah S.
Aljahdli, and CBRC PI is Professor Vladimir Bajic.